Cutler Group’s EnteroMedics Inc. ETRM Stock Holding History

Cutler Group’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1	Closed	-$1K	–	8000
2015 Q4	$1K	Buy	+1	New	+$207	﹤0.01%	6317

Other funds holding ETRM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

Cutler Group's ETRM Position: Q2 2017 in Review

Cutler Group sold out of EnteroMedics Inc. (ETRM) in Q2 2017, closing a stake of 602 shares — an estimated $3K sold.

Cutler Group first reported a position in ETRM in Q4 2015 and held it in 6 quarters. The position peaked at $82K in Q4 2015. 16 funds tracked by Wall St. Rank hold ETRM as of Q2 2017.

Cutler Group reported no remaining EnteroMedics Inc. position as of Q2 2017 after selling out during the quarter.
Cutler Group sold 602 EnteroMedics Inc. shares in Q2 2017, an estimated $3K.
Cutler Group first reported a position in EnteroMedics Inc. in Q4 2015 and held it in 6 quarters.
Cutler Group's EnteroMedics Inc. position peaked at $82K in Q4 2015.
16 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.